date:Feb 21, 2013
. In 2013 we will focus on the operational performance and integration of the acquisitions we completed in 2012 with special attention to capturing synergies. We expect strong EBITDA growth in 2013, moving towards 1.4 billion. The Boards proposal to increase the dividend for the third consecutive year is testament to the stronger DSM we have built in recent years, with more stable growth and profitability going forward.
Nutrition results in Q4 increased by 6% versus Q4 2011 and full year result